LIFE SCIENCES
____________________________________________________________________
Adventus Technology (Australia) Pty Ltd
Born from the Vision Cooperative Research Centre (Vision CRC), the world’s largest vision correction research centre, Adventus Technology (Australia) Pty. Ltd (“Adventus”) aims to further the development, approval and commercialisation of two new ophthalmic products which have the potential to both revolutionise the global ophthalmic device market and underpin a new era for the more than 50% of the world’s population who need vision correction.
The Adventus’ mission is to bring unique products to the vision correction (refractive eye care) market. The company plans to develop and bring to market well designed, efficacious, best quality evolutionary and revolutionary products with very broad application and appeal.
Contact: Daniel Holden +61 425 242 252 | E-mail: d.holden@adventustechnology.com
| Website: www.adventustechnology.com
____________________________________________________________________
AiMedics
Inventors of HypoMon ®, an effective non-invasive, real-time warning system for the detection of hypoglycaemia (low blood-glucose) in Type I insulin-dependent diabetic patients. Medical and physiological conditions that the technology has applications include diabetes, SIDS, epilepsy and fatigue.
Contact: Nejhdeh Ghevondian +61 2 9209 4514 | E-mail: nejhdeh@aimedics.com | Website: www.aimedics.com
_____________________________________________________________________
Better Health and Wellness
Better Health & Wellness Solutions (BHW) has developed a totally natural sweetener that is now available for food manufacturers to use to help in the fight against obesity and make traditionally unhealthy food and beverage products “better for you”. SweeTose is a totally natural protein that tastes sweet and unlike other products on the market, SweeTose has a much lower calorific value and GI rating. The technology has been developed locally in Australia and The Manildra group is the licensed partner for manufacture and distribution of SweeTose for the food and beverage industry.
Contact: Jimmy Seervai + 61 2 9209 4044 | Email: jimmy@bhw.net.au | Website: www.bhw.net.au
_____________________________________________________________________
Bioline (Aust) Pty Ltd
Bioline Australia is a primary manufacturer of high quality Molecular Biology Reagents. The company has a dedicated R&D facility in the Australian Technology Park and produces product lines for domestic and export markets. Bioline Australia aims to create collaborative research partnerships within Australia, targeting both academic and industrial entities. Bioline Australia’s research, production and distribution systems are all ISO9001:2000 accredited.
Contact: Colin Denver +61 2 9209 4180 | E-mail: cdenver@bioline.com | Website: www.bioline.com
_____________________________________________________________________
BioProcess
Bioprocess develops technologies and owns intellectual property rights pertaining to a proprietary, highly effective E.coli-based vector system designed to accommodate a wide range of gene constructs for high level protein expression, including blood viral key components for use in developing in-vitro diagnostics.
Contact: Torsten Helting +61 9209 4086 | E-mail: helting@bioprocess.com.au | Website: www.bioprocess.com.au
_____________________________________________________________________
Chemeq Technologies
Chemeq Technologies Pty Ltd has developed and patented a unique anti-microbial polymer providing the human health, personal care, specialized industrial markets and animal health markets with a safe, effective and resistance-free alternative to antibiotics and conventional biocides.
Contact: Bill McHenry +61 2 9209 4863| E-mail: bill.mchenry@chemeqtechnologies.com | Website: www.chemeqtechnologies.com
_____________________________________________________________________
Elastagen
Armed with an exclusive license to an extensive patent portfolio of technologies developed at the University of Sydney, Elastagen is a medical device company focused on the production and formulation of synthetic human Elastin for cosmetic and plastic surgery applications. The elastin based biomaterial offers a range of exciting technological and positioning advantages over the presently saturated hyaluronic acid and animal-derived collagen based product market, and significantly the potential to differentiate and establish a highly desirable proprietory position in this globally growing high value market segment.
Contact: Orsola Regaglia +61 2 9209 4054 | E-mail: o.regaglia@elastagen.com |Website: www.elastagen.com
_____________________________________________________________________
Endoluminal Sciences
Endoluminal Sciences is an early stage venture capital-backed company, committed to the development of novel platform technologies to dramatically enhance the clinical performance of endovascular prostheses. While the technology is foreseen to have its application to a range of vascular disease states, the immediate focus is the treatment of abdominal aortic aneurysms (AAAs).
Contact: Ashish Mitra +61 2 9209 4213 | E-mail: amitra@endoluminalsciences.com | Website: www.endoluminalsciences.com
_____________________________________________________________________
E-Nose
E-Nose Pty Ltd designs, builds and distributes electronic noses. These chemical sensor array devices monitor, identify and measure smells and other airborne chemicals continuously and in real time.
Our devices consist of arrays of robust and fast acting chemical sensors, supplemented by novel patented electronics and software. Chemicals in the air are detected by the sensor arrays, registering complex odour “images” in real time.
A permanent record is sent to your computer via line or wireless connection, where it is identified, quantified and alarms for abnormal events.
Contact: Graham Bell +61 2 9209 4083 | E-mail: g.bell@atp.com.au | Website: www.chemosensory.com
_____________________________________________________________________
Innovation Dynamics
Innovation Dynamics provides independent, high quality, advice to technology-based organisations and companies to help them manage change. Innovation Dynamics has a series of products and methodologies that provide solutions to our clients. We tailor our work to our customers' needs and have in-depth expertise applicable to government, industry and not-for-profit organisations.
Contact: Kelvin Hopper +61 9209 4231 | E-mail: khopper@innovationdynamics.com.au | Website: www.innovationdynamics.com.au
_____________________________________________________________________
Innovative Purification Technologies Pty Ltd
Innovative Purification Technologies Pty Ltd (IPT) is developing and commercialising novel separation technologies for biologically active macromolecules.
IPT was founded in August 2005 and is now building a strong portfolio of novel and innovative solutions for purification of biopharmaceuticals and research grade proteins.
Contact: Jens Sommer Knudsen +61 9209 4214 | E-mail: jsk@innopurtech.com | Website: www.innopurtech.com
_____________________________________________________________________
ITL Design & Manufacturing
ITL Design & Manufacturing is part of a publicly listed company, we provide innovative solutions and services to help take our clients ideas to market.
We work with entrepreneurs, spin offs, start ups and established companies across a range of areas including: medical devices, consumer products, scientific products, IT and telecommunications
Contact: Steven Mayall +61 2 8394 4800 | E-mail: info@itldesign.com | Website: www.itldesign.com
_____________________________________________________________________
Mamprotech
Mamprotech specialises in the production of fully glycosylated recombinant human proteins and the development of cell clones for the biomanufacturing and biopharmaceutical industry. Mamprotech utilises mammalian cells as protein factory due to their unique ability to provide right environment and cellular machinery for correct processing of functional proteins for therapeutic and research purposes.
Contact: Giang Tran +61 2 9209 4951 | E-mail: giang@mamprotech.com
_____________________________________________________________________
Medsaic
Medsaic focuses on the commercialisation of a micro-array based rapid assay platform for the detection of all chemical entities. Medsaic's technology is being initially developed using monoclonal antibodies and will compete in the diagnostic, drug discovery and therapeutic markets.
Contact: Sarah Serafini +61 2 9209 4445 | E-mail: s.serafini@medsaic.com | Website: www.medsaic.com
_____________________________________________________________________
Neuclone
NeuClone is a biotechnology company built on strengths in mammalian cell line engineering. The company is specializing in the generation of cell lines producing complex therapeutic proteins with a focus on biogenerics or biosimilars. NeuClone has an integrated cell expression platform technology named NeuCHOTM and is comprised of an engineered Chinese Hamster Ovary (CHO) host cell line, and an efficient expression vector system. NeuClone's cell expression system is very competitive in the market place as it provides an enhanced level productivity compared to current expression systems thus lowering the cost of large scale bio-manufacturing processes. The company is building its portfolio of engineered cell lines expressing biosimilars. These cell lines are licensed to generic manufacturers of biological drugs and the company is generating income through development contracts, licensing fees and royalty streams.
Contact: Noelle Sunstrom +61 2 9209 4020 | E-mail: n.sunstrom@neuclone.com | Website: www.neuclone.com
_____________________________________________________________________
SpeeDx
SpeeDx Pty Ltd is focused on the development of catalytic nucleic acid enzymes for medical diagnostics and other applications. Our key technologies include MNAzymes and DNAzymes which provide the basis for a suite of highly specific and cost-effective methods for analysis of biological materials.
Contact: Caroline Fuery +61 2 9209 4170 | E-mail: info@speedx.com.au | Website: www.speedx.com.au
_____________________________________________________________________
Stephen Sanig Research Institute
SSRI builds upon Australia's outstanding pool of primary medical research and works in collaboration with academic institutions in Australia and overseas to develop industrially viable biopharmaceutical products. Its activities include (i) research & development and the production of pharmaceutical products, which can be used for the improvement of public health, e.g. inflammatory diseases, cancer, etc.; (ii) educational programs for the public to broaden public awareness and facilitate a better practice for dealing with these health problems.
Contact: Tohsak Mahaworasilpa +61 2 9209 4117 | E-mail: t.mahaworasilpa@ssri.org.au | Website: www.ssri.org.au
_____________________________________________________________________
Vaxine Pty Ltd
Vaxine is a vaccine company focused on developing & producing vaccine products for the treatment & prevention of infectious & cancer diseases. The company is commercialising world-class Australian vaccine research based on novel adjuvant technology. Results from a recent phase I clinical trials on a HBV vaccine with this technology have shown a clean safety performance with a strong cell-mediated as well as a humoral response.
Contact: Ted Stapinski +61 2 6229 1733 | E-mail: ted.stapinski@vaxine.com.au | Website: www.vaxine.net
_____________________________________________________________________